Risk Management Back
This Module is the 4th part of the MHRA/DIA Excellence in Pharmacovigilance training course
It is possible to register for each of the 4 course modules separately:
Module 1: Definitions and Methods in Pharmacovigilance
It is possible to register for the 5 days training course:
This module aims also to provide the background for understanding drug-related risks, and to present recent developments regarding risk communication.
In accordance with the GVP Module V on Risk Management System, risk management plans (RMPs) should be submitted by companies to propose activities aiming to identify, characterise or minimise risks associated with medicinal products. Given the potential public health implications and costs of such interventions, RMPs should be based on robust epidemiological methods.